Metformin: are potential benefits on cancer risk extended to cancer survival?
- PMID: 24258614
- PMCID: PMC3868416
- DOI: 10.1634/theoncologist.2013-0381
Metformin: are potential benefits on cancer risk extended to cancer survival?
Conflict of interest statement
Disclosures of potential conflicts of interest may be found at the end of this article.
Comment on
-
Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.Oncologist. 2013;18(12):1248-55. doi: 10.1634/theoncologist.2013-0111. Epub 2013 Nov 20. Oncologist. 2013. PMID: 24258613 Free PMC article.
Similar articles
-
The effect of metformin on mortality following cancer among patients with diabetes.Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1974-84. doi: 10.1158/1055-9965.EPI-14-0327. Epub 2014 Jul 16. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 25030683
-
[Metformin can reduce the risk of colorectal cancer].Ugeskr Laeger. 2015 May 18;177(21):V12140659. Ugeskr Laeger. 2015. PMID: 26027593 Review. Danish.
-
Metformin and colorectal cancer risk in diabetic patients.Diabetes Care. 2011 Oct;34(10):2336-7. doi: 10.2337/dc11-1447. Diabetes Care. 2011. PMID: 21949227 Free PMC article. No abstract available.
-
Association between pancreatic cancer and metformin use in patients with type 2 diabetes.Postgrad Med J. 2019 May;95(1123):291. doi: 10.1136/postgradmedj-2019-136463. Epub 2019 Apr 11. Postgrad Med J. 2019. PMID: 30975725 No abstract available.
-
Metformin in cancer treatment and prevention.Annu Rev Med. 2015;66:17-29. doi: 10.1146/annurev-med-062613-093128. Epub 2014 Nov 6. Annu Rev Med. 2015. PMID: 25386929 Review.
References
-
- Bosetti C, Rosato V, Polesel J, et al. Diabetes mellitus and cancer risk in a network of case-control studies. Nutr Cancer. 2012;64:643–651. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical